ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
194,00
0,00
(0,00%)
Fermé 08 Octobre 5:30PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
194,00
Prix Achat
186,00
Prix Vente
200,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
148,00 Plage de 52 semaines 202,00
Cap du marché
Clôture Veille
194,00
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
25
Actions en circulation
4 150 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
28,51
Bénéfice par action (BPA)
6,8
Chiffre d'affairess
362,44M
Bénéfice net
28,24M

À propos de Spadel SA

Secteur
Btld & Can Soft Drinks,water
Industrie
Btld & Can Soft Drinks,water
Site Web
Siège social
Brussels, Brussels-capital Region, Bel
Fondé
1980
Spadel SA est coté dans le secteur Btld & Can Soft Drinks,water de la Euronext avec le ticker SPA. Le dernier cours de clôture d'Spadel était de 194,00 €. Au cours de la dernière année, les actions de Spadel ont été négociées dans une fourchette de prix de 148,00 € à 202,00 €.

Spadel compte actuellement 4 150 000 actions en circulation. La capitalisation boursière d'Spadel est de 805,10 € million. Spadel a un ratio cours/bénéfice (ratio PE) de 28.51.

SPA Dernières nouvelles

Research Update

SR Pharma plc Research Update London 23 December 2003 - Corixa Corporation (Corixa) and Genesis Research and Development Corporation Limited (Genesis) announced yesterday that they had...

Holding(s) in Company

SR Pharma plc Holding in Company London 16 December 2003 - SR Pharma plc ("the Company") was informed today by the Royal Bank of Scotland Group plc that the Royal Bank of Scotland Group plc and...

Research Update

SR Pharma plc and EiRx Therapeutics Ltd sign research deal `New molecules for potential cancer treatments' London, 1 December 2003 - SR Pharma and EiRx Therapeutics today announced that they...

Interim Results

SR PHARMA PLC UNAUDITED INTERIM RESULTS FOR THE 6 MONTHS ENDED 30 JUNE 2003 SR Pharma plc, the London based biopharmaceutical company, today announces its unaudited interim results for the six...

Start of AVAC phase II clinical trial

SR Pharma and Genesis Research Initiate Phase II Trial of AVAC(tm) in Childhood Eczema London and Auckland, 10 September 2003 - London-based biopharmaceutical company SR Pharma (LSE: SPA) and its...

Directorate Change

Death of non-executive director of SR Pharma plc London, 23 July 2003 - SR Pharma plc regretfully announces the death of Professor Tim Chard who was a non-executive director of the company...

Resignation

RNS Number:7085N SR Pharma PLC 18 July 2003 18th July, 2003 TO: CITY EDITORS FOR IMMEDIATE RELEASE SR Pharma plc Resignation of executive director SR Pharma plc today announces...

SR Pharma completes enrolment of asthma clinical trial

SR Pharma completes enrolment of phase II clinical trial for asthma London, UK. 24 June 2003*SR Pharma plc (LSE: SPA) today announces the completion of enrolment in its phase II European clinical...

CEO Appointment

SR Pharma Appoints Dr David Hill As Chief Executive Officer London, UK. 19 May 2003SR Pharma plc (LSE: SPA) announces the appointment today of Dr David Hill as Chief Executive Officer and a member...

AGM Statement

SR Pharma Annual General Meeting London, UK. 19 May 2003 At today's Annual General Meeting, Chairman Eric Boyle said: "SR Pharma retains a robust cash position and a well diversified product...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10019419419400DE
4-5-2.5125628140719919918914192.14388489DE
1242.1052631578919020217325196.73801485DE
264126.797385620915320215344181.38188153DE
523421.2516020214856165.54555712DE
156147.7777777777818020214834167.19972931DE
26000194208148115185.3056616DE

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ALEUPEuroplasma
0,196 €
(67,24%)
3,79M
MLFXOFinaxo
0,91 €
(50,41%)
68
ALVETTheraVet SA
0,138 €
(38,55%)
21,47k
ALDVIAdvicenne
1,90 €
(33,80%)
252,78k
ALHPIHopium SA
0,0189 €
(30,34%)
14,27M
COBS3Casino Guichard Perrachon
0,0005 €
(-50,00%)
651,96k
ALBOOBOOSTHEAT
0,254 €
(-27,01%)
1,03k
BEVERBever Beleg
2,60 €
(-18,75%)
600
ALARFAdeunis
0,528 €
(-18,52%)
12,42k
MLEFAEduformAction
0,41 €
(-15,64%)
1 000
BCPBanco Comercial Portugues SA
0,4104 €
(3,25%)
73,65M
ALAVEAventador
0,002 €
(-9,09%)
17,75M
ALCYBCybergun
0,0001 €
(0,00%)
16,43M
LOCALSolocal Groupe
0,0026 €
(-7,14%)
15,48M
ALHPIHopium SA
0,0189 €
(30,34%)
14,27M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock